Infusystem Holdings (INFU) revenue and earnings history
Infusystem Holdings reported revenue of $143M for fiscal 2025 (year ended Dec 31, 2025), +6.4% on the year before, and net income of $6.63M.
Over 16 years, from fiscal 2009 to fiscal 2025, revenue grew at a compound rate of +8.5% a year.
Revenue and net income, 17 fiscal years
Annual figures, newest first
| Fiscal year | Revenue | Operating income | Net income | Operating cash flow | Capital expenditure | Free cash flow | Stock-based pay | Share buybacks | Dividends paid | Cash at year end | Total debt at year end | Report |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025ended Dec 31, 2025 | $143M+6.4% | $11.9M | $6.63M | $24.4M | $560K | $23.8M | $4.36M | $9.87M | — | $3.19M | $19.6M | 10-K |
| 2024ended Dec 31, 2024 |
The latest quarter, insider trades and fund moves: Infusystem Holdings (INFU) on OQRO.
Common questions
What was Infusystem Holdings's revenue in fiscal 2025?
$143M for the year ended Dec 31, 2025, as reported in its 10-K filed Feb 27, 2026. That is +6.4% on fiscal 2024 ($135M).
How fast has Infusystem Holdings's revenue grown?
From $39M in fiscal 2009 to $143M in fiscal 2025: a compound annual growth rate of +8.5% over 16 years. This is arithmetic on the filed figures and says nothing about the years ahead.
Where these figures come from
The SEC’s companyfacts data: every figure Infusystem Holdings tagged in XBRL in its annual and quarterly reports since 2009 (some reports carry a few earlier years as comparatives). For each fiscal year OQRO keeps the twelve-month totals from the annual report and the cash and debt at year end, and when a later report restates a year, the later figure. Read again whenever the company files.
Figures are as reported, in US dollars, with no adjustment for acquisitions, disposals or one-off items. Earnings per share are left out because a stock split changes them between reports. This page describes the past and is not investment advice. No language model wrote it.
